INNOVO® is a clinically proven device

A 26-week pilot study of women with stress urinary incontinence who followed the Innovotherapy treatment regimen for 12 weeks found significant improvement in their symptoms:

  • An improvement in the amount of involuntary urine leaked over 1 hour in 93% of INNOVO® users after 4 weeks of treatment, where 60% were defined as dry1 

1h stress test

  • An average 74% reduction in involuntary urine loss over 24 hours after 12 weeks of treatment, where 86% of INNOVO® users were defined as dry or almost dry2 

24h stress test

  • An improvement in the Modified Oxford Score (standing position) after treatment with Innovotherapy, where 79% of patients had good or moderate pelvic floor muscle contractions at 12 weeks, compared with 6% at baseline1 

Improvement in contractility

 Patients’ pelvic floor muscle contractility improved over 12 weeks of  INNOVO® treatment

 

Innovo is a clinical proven device

1) 1) Soeder S, Tunn R. Neuromuscular electrical stimulation (NMES) of the pelvic floor muscles using a non-invasive surface device in the treatment of stress urinary incontinence (SUI); a pilot study. IUGA Poster Presentation Conference, 2013; Dublin, Ireland.